NCM
Northland Capital Markets Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
226
MP Materials
MP
$11.3B
| $63.88 | $60 |
6%
downside
| Outperform |
6 Jun ‘22
3 years ago |
|
|
227
Array Technologies
ARRY
$1.2B
|
DS
Donovan Schafer
| $7.84 | $18 |
130%
upside
| Outperform |
23 May ‘22
3 years ago |
|
228
KALA BIO
KALA
$130M
|
TC
Tim Chiang
| $18.57 | $199.80 |
976%
upside
| Outperform |
30 Mar ‘22
3 years ago |
|
229
iRobot
IRBT
$111M
|
ML
Michael Latimore
| $3.54 | $85 |
2,301%
upside
| Outperform |
24 Mar ‘22
3 years ago |
|
230
Veritone
VERI
$213M
|
ML
Michael Latimore
| $3.86 | $30 |
677%
upside
| Outperform |
4 Mar ‘22
3 years ago |
|
231
Grid Dynamics Holdings
GDYN
$644M
|
TS
Tim Savageaux
| $7.61 | $22.50 |
196%
upside
| Outperform |
4 Mar ‘22
3 years ago |
|
232
DocGo
DCGO
$150M
|
ML
Michael Latimore
| $1.53 | $22 |
1,338%
upside
| Outperform |
30 Nov ‘21
3 years ago |
|
|
FIEE
233
FiEE, Inc Common Stock
FIEE
$17.6M
|
TS
Tim Savageaux
| $2.83 | $75 |
2,550%
upside
| Outperform |
25 Oct ‘21
3 years ago |
|
234
Protagonist Therapeutics
PTGX
$3.7B
|
TC
Tim Chiang
| $59.41 | $40 |
33%
downside
| Outperform |
11 Oct ‘21
3 years ago |
|
235
SAB Biotherapeutics
SABS
$22.2M
|
TC
Tim Chiang
| $2.13 | $180 |
8,351%
upside
| Outperform |
4 Oct ‘21
3 years ago |
|
|
SEGG
236
Lottery.com
SEGG
$21.5M
|
GG
Greg Gibas
| $5.45 | $3,200 |
58,616%
upside
| Outperform |
21 Sep ‘21
4 years ago |
|
237
Perspective Therapeutics
CATX
$255M
|
TC
Tim Chiang
| $3.44 | $12.50 |
263%
upside
| Outperform |
14 Sep ‘21
4 years ago |
|
238
Stryker
SYK
$147B
|
JW
Jason Wittes
| $384.71 | $310 |
19%
downside
| Outperform |
28 Jul ‘21
4 years ago |
|
239
MiMedx Group
MDXG
$1.03B
|
CB
Carl Byrnes
| $6.97 | $23 |
230%
upside
| Outperform |
26 Jul ‘21
4 years ago |
|
240
Wendy's
WEN
$1.85B
|
JS
Jim Sanderson
| $9.69 | $30 |
210%
upside
| Buy |
14 Jun ‘21
4 years ago |
|
241
Comtech Telecommunications
CMTL
$67.9M
|
ML
Michael Latimore
| $2.31 | $28 |
1,112%
upside
| Outperform |
9 Jun ‘21
4 years ago |
|
242
TMC The Metals Company
TMC
$2.15B
|
SC
Subash Chandra
| $5.29 | $20 |
278%
upside
| Outperform |
27 May ‘21
4 years ago |
|
243
GrowGeneration
GRWG
$102M
|
MG
Mike Grondahl
| $1.70 | $55 |
3,135%
upside
| Outperform |
10 May ‘21
4 years ago |
|
244
NWPX Infrastructure, Inc. Common Stock
NWPX
$503M
|
GR
Gus Richard
| $52.07 | $38 |
27%
downside
| Outperform |
5 May ‘21
4 years ago |
|
245
Esperion Therapeutics
ESPR
$571M
|
CB
Carl Byrnes
| $2.83 | $24 |
748%
upside
| Market Perform |
5 May ‘21
4 years ago |
|
246
Pacira BioSciences
PCRX
$1.22B
|
TC
Tim Chiang
| $27.21 | $66 |
143%
upside
| Market Perform |
5 May ‘21
4 years ago |
|
247
Devon Energy
DVN
$22.2B
|
DB
Doug Becker
| $34.92 | $30 |
14%
downside
| Outperform |
5 May ‘21
4 years ago |
|
248
InfuSystem Holdings
INFU
$206M
|
JT
James Terwilliger
| $10.08 | $27 |
168%
upside
| Outperform |
26 Apr ‘21
4 years ago |
|
|
BWAY
249
Brainsway
BWAY
$296M
|
JW
Jason Wittes
| $15.67 | $15 |
4%
downside
| Outperform |
20 Apr ‘21
4 years ago |
|
250
NovoCure
NVCR
$1.38B
|
JW
Jason Wittes
| $12.35 | $250 |
1,924%
upside
| Outperform |
14 Apr ‘21
4 years ago |
|